A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We deliver transformative solutions that power real results. See how we can help.
Optimizing Supply Chain
Maximizing Value-Based Care
Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.
At every level of leadership, Premier’s experts are driving healthcare forward.
Board of Directors
Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.
Find Out How
Collective purchasing power lowers costs across your organization.
Intelligence plus unparalleled analytics equals data-driven solutions.
It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.
Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.
A voice for better healthcare policy is a voice for you.
Working closely with our members, we’re developing products and services to solve your most complex challenges.
Lower costs, greater efficiencies and a healthier bottom line.
Proven practices that result in better outcomes.
Intersecting specialty drugs with better management and data-driven best practices.
Controlling your future with integrated care delivery practices.
More savings and ROI is a win-win.
Data diving to deliver insights you can act on.
Data, inquiry and intervention services.
Our most recent insights, articles and more, all in one place.
View Our Latest
Discover what leading healthcare providers are achieving through Premier membership.
Stay informed with our white papers, webinars and e-books.
Browse our blog for a taste of what’s new and what’s next in healthcare.
Premier’s perspectives have been solicited by nationally renowned publications. Read on.
Read Premier’s latest announcements.
Catch our policy statements and perspectives on the latest in DC.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
The bill provides a critical infusion of funding for the healthcare system to respond to the COVID-19 pandemic.
Providers are facing severe financial difficulties as they are provide care for those infected with COVID-19 and for those with other conditions.
These steps help ensure our health system's readiness by placing equal urgency on all medical supplies, resources and services.
Given the circumstances of COVID-19, Premier and America’s Physician Groups encourage HHS to ensure policies are in place for providers in value-based programs.
The Executive Order creates opportunity for the U.S. to increase domestic manufacturing quickly to protect the public in light of the global pandemic.
Healthcare Innovation |
Premier's Meryl Bloomrosen comments on the timelines for interoperability rules especially considering the coronavirus outbreak.
The final rules make significant progress in addressing the economic incentives that impede health IT market competition.
The bipartisan Preventing Drug Shortages Act will shed light on the true risk of shortages of essential drugs and medical supplies.
The Act helps mitigate drug shortages and develop market-based incentives to help ensure a stable supply of medications.
This legislation is essential to remove one of the main barriers to coordinating care for patients struggling with substance use
This approach will ensure that healthcare providers have the information they need to improve treatment for substance use disorders.
Creating incentives for domestic manufacturing is urgently needed to ensure a steady supply of vital drugs and medical supplies.
Premier supports the MEDS Act as a holistic and sustainable approach to eliminating drugs shortages and addressing vulnerabilities in the drug supply chain.
It's clear Congress needs to take additional steps to prevent gaps in vital medical supplies.
Premier calls on CMS to build on the successes of Next Generation ACOs.
CMS’ proposal to change the definition of an ‘episode of care’ to include outpatient procedures aligns with Premier’s recommendations.
Despite these successes, the NGACO model is set to sunset at the end of 2020 and CMS has indicated it does not plan to extend it.
Premier applauds the FDA’s new approach to prioritizing the review of generic drug applications.
Soumi Saha comments on how Premier is implementing and measuring improvement efforts in the fight against AMR.
MedTech Intelligence |
Premier's Chaun Powell and Soumi Saha explain why 2020 should be a pivotal year for medical device sterilization.
While the states have made major strides in reducing opioid overdose deaths and harm, there is still much work to be done.